NCT02754596 - Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic Solution | Biotech Hunter

Enrollment

154

Participants

Timeline

Start Date

March 29, 2016

Primary Completion Date

August 1, 2017

Study Completion Date

July 21, 2020

Conditions

Glaucoma Open-angle

Interventions

DRUG

Travoprost Intraocular Implant, high elution

Surgical implant placed within the eye to elute travoprost.

DRUG

Travoprost Intraocular Implant, low elution

Surgical implant placed within the eye to elute travoprost

DRUG

Timolol Maleate Ophthalmic Solution, 0.5%

Instillation of one drop of timolol in the study eye twice daily

Trial Locations (1)

John Berdahl, MD, Sioux Falls